This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Carpenter Receives £300,000 After Developing Mesothelioma

LONDON, April 4, 2013 /PRNewswire/ --

A Kent man who developed a painful lung cancer after he was exposed to asbestos through his work in the 1980s and '90s has received £300,000 in an out-of-court settlement after making a Mesothelioma Claim.

Peter Olszewski, an industrial disease specialist at Fentons Personal Injury Solicitors LLP, said the former carpenter, who is now in his 50s, was diagnosed with mesothelioma in early 2012 following a prolonged period of increasing breathlessness and chest pains.

"My client was exposed to asbestos whilst working for three Kent-based shop-fitting firms more than 30 years ago," said Peter, a solicitor with the firm. "His job at all three firms involved refitting retail premises. Using hammers, crowbars and saws, he and his colleagues would gut the premises and remove all the old pipe work, electrical fittings, ceilings and walls before disposing of the material in skips and refitting the shops from scratch.

"The pipes they exposed were often covered in old asbestos lagging," added Peter. "It was their job to smash and cut the existing pipe work away from the building so it could be replaced. Unsurprisingly, the work produced a tremendous amount of thick grey asbestos dust which would hang in the air for them to inhale and get all over their hands, faces and clothes."

Peter said his client's employers never provided him with any kind of personal protective equipment such as face masks or breathing apparatus. "In addition, there were no ventilation measures in place and there were no on-site showers," he said. "As he was never given any clean overalls or means to wash himself he would always go home completely covered in asbestos fibres.

"My client approached me shortly after he was diagnosed with mesothelioma last year," said Peter. "He had been complaining of chest pains and shortness of breath for months before chest x-rays revealed he had a build-up of fluid in his lungs. Following various procedures to drain his lungs, he then underwent a series of biopsies which ultimately led to his diagnosis.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 17,784.60 +64.68 0.36%
S&P 500 2,094.75 +14.34 0.69%
NASDAQ 5,141.7740 +33.1080 0.65%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs